38 related articles for article (PubMed ID: 12905459)
1. Carcinogenesis: The more we seek to know the more we need to know - Challenges in the post Genomic Era.
Kovvali G; Shiff S; Telang N; Das K; Kohgo Y; Narayan S; Li H
J Carcinog; 2003 Jan; 2(1):1. PubMed ID: 12605710
[No Abstract] [Full Text] [Related]
2. Infections in the Era of Targeted Therapies: Mapping the Road Ahead.
Calabrese LH; Calabrese C; Lenfant T; Kirchner E; Strand V
Front Med (Lausanne); 2020; 7():336. PubMed ID: 32974356
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-889 Inhibits Autophagy To Maintain Mycobacterial Survival in Patients with Latent Tuberculosis Infection by Targeting TWEAK.
Chen DY; Chen YM; Lin CF; Lo CM; Liu HJ; Liao TL
mBio; 2020 Jan; 11(1):. PubMed ID: 31992621
[TBL] [Abstract][Full Text] [Related]
4. Positiveness of purified protein derivatives in rheumatoid arthritis patients who are not receiving immunosuppressive therapy.
Sezer I; Kocabas H; Melikoglu MA; Arman M
Clin Rheumatol; 2009 Jan; 28(1):53-7. PubMed ID: 18688673
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.
Sellam J; Hamdi H; Roy C; Baron G; Lemann M; Puéchal X; Breban M; Berenbaum F; Humbert M; Weldingh K; Salmon D; Ravaud P; Emilie D; Mariette X;
Ann Rheum Dis; 2007 Dec; 66(12):1610-5. PubMed ID: 17456528
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression related to collagen-vascular disease or its treatment.
Hamilton CD
Proc Am Thorac Soc; 2005; 2(5):456-60. PubMed ID: 16322600
[TBL] [Abstract][Full Text] [Related]
7. Miliary tuberculosis after infliximab therapy in Lebanon.
Uthman I; Kanj N; El-Sayad J; Bizri AR
Clin Rheumatol; 2004 Jun; 23(3):279-80. PubMed ID: 15168166
[No Abstract] [Full Text] [Related]
8. Why does tumor necrosis factor targeted therapy reactivate tuberculosis?
Ehlers S
J Rheumatol Suppl; 2005 Mar; 74():35-9. PubMed ID: 15742463
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis in the cytokine era: what rheumatologists need to know.
Hamilton CD
Arthritis Rheum; 2003 Aug; 48(8):2085-91. PubMed ID: 12905459
[No Abstract] [Full Text] [Related]
10. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
[TBL] [Abstract][Full Text] [Related]
11. [TNF-alpha blockers, rheumatoid arthritis and pulmonary tuberculosis].
Mihăltan F
Pneumologia; 2007; 56(4):212-6. PubMed ID: 18320798
[No Abstract] [Full Text] [Related]
12. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy.
Iliopoulos A; Psathakis K; Aslanidis S; Skagias L; Sfikakis PP
Int J Tuberc Lung Dis; 2006 May; 10(5):588-90. PubMed ID: 16704045
[TBL] [Abstract][Full Text] [Related]
13. [Recommendations of the German Society of Rheumatology for therapy with tumor necrosis factor inhibitors. Pharmacotherapy Committee of the German Society of Rheumatology].
Z Rheumatol; 2000 Aug; 59(4):291-2. PubMed ID: 11013988
[No Abstract] [Full Text] [Related]
14. Detection of tuberculosis by extensive screening in a patient with rheumatoid arthritis prior to anti-TNF-alpha therapy.
Iseli A; Hüllstrung HD; Rodenhausen S; Widmer AF; Tyndall A; Hasler P
Rheumatology (Oxford); 2006 Aug; 45(8):1049-50. PubMed ID: 16769772
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
